Australia markets closed

MEDIROM Healthcare Technologies Inc. (MRM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.26+0.04 (+0.77%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.68M
Enterprise value 45.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.64
Price/book (mrq)N/A
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.23

Trading information

Stock price history

Beta (5Y monthly) 0.02
52-week change 3-5.52%
S&P500 52-week change 322.38%
52-week high 37.40
52-week low 33.50
50-day moving average 35.98
200-day moving average 35.65

Share statistics

Avg vol (3-month) 32.27k
Avg vol (10-day) 31.9k
Shares outstanding 54.88M
Implied shares outstanding 65.09M
Float 83M
% held by insiders 140.37%
% held by institutions 10.00%
Shares short (15 Apr 2024) 44.31k
Short ratio (15 Apr 2024) 41.57
Short % of float (15 Apr 2024) 40.15%
Short % of shares outstanding (15 Apr 2024) 40.09%
Shares short (prior month 15 Mar 2024) 42.92k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -0.35%
Operating margin (ttm)-9.57%

Management effectiveness

Return on assets (ttm)-0.64%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.05B
Revenue per share (ttm)1,445.40
Quarterly revenue growth (yoy)3.00%
Gross profit (ttm)N/A
EBITDA 134.9M
Net income avi to common (ttm)-24.56M
Diluted EPS (ttm)-0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)117.73M
Total cash per share (mrq)24.11
Total debt (mrq)3.27B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.48
Book value per share (mrq)-84.88

Cash flow statement

Operating cash flow (ttm)-1.01B
Levered free cash flow (ttm)-246.89M